In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.
The in vitro activities of rufloxacin and its metabolite, MF 922, were compared with those of ofloxacin, ciprofloxacin, erythromycin, and minocycline against Mycoplasma pneumoniae, Mycoplasma hominis, Mycoplasma fermentans, and Ureaplasma urealyticum. Rufloxacin, MF 922, and ciprofloxacin shared sim...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
1994
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188257/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7872762/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.11.2651 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|